2. WHO Classification of Tumours Editorial Board. WHO classification of tumours. 5th ed. Vol. 8. Lyon: International Agency for Research on Cancer; 2021. Chapter 2, Tumours of the kidney; pp. 72–3.

3. Masago T, Kobayakawa S, Ohtani Y, Taniguchi K, Naka T, Kuroda N, et al. Xp11.2 translocation renal cell carcinoma with TFE3 gene fusion in the elderly: case report and literature review. Int Cancer Conf J. 2020 Jul 8;9(4):182–6. 10.1007/s13691-020-00430-6

4. Calio A, Segala D, Munari E, Brunelli M, Martignoni G. MiT family translocation renal cell carcinoma: From the early descriptions to the current knowledge. Cancers (Basel). 2019 Aug 3;11(8):1110. 10.3390/cancers11081110

5. Armah HB, Parwani AV. Xp11.2 translocation renal cell carcinoma. Arch Pathol Lab Med. 2010 Jan 134(1):124–9. 10.5858/2008-0391-RSR.1

6. Koie T, Yoneyama T, Hashimoto Y, Kamimura N, Kusumi T, Kijima H, et al. An aggressive course of Xp11 translocation renal cell carcinoma in a 28-year-old man. Int J Urol. 2009 Mar;16(3):333–5. 10.1111/j.1442-2042.2008.02231.x

7. Cheng X, Gan W, Zhang G, Li X, Guo H. Clinical characteristics of XP11.2 translocation/TFE3 gene fusion renal cell carcinoma: A systematic review and meta-analysis of observational studies. BMC Urol. 2016 Jul 16(1):40. 10.1186/s12894-016-0154-6

8. Zhou J, Zhao L, Yang Z, Chen Y, Wu X, Xue W. Clinicopathologic, treatment and prognosis study of 46 Xp11.2 translocation/TFE3 gene fusion renal cell carcinomas. BMC Urol. 2022 Jul 18;22(1):109. 10.1186/s12894-022-01060-1

9. Chung EM, Lattin GE, Fagen KE, Kim AM, Pavio MA, Fehringer AJ, et al. Renal tumors of childhood: Radiologic-pathologic correlation part 2. The 2nd decade: From the radiologic pathology archives. Radiographics. 2017 Sep–Oct;37(5):1538–58. 10.1148/rg.2017160189

10. Woo S, Kim SY, Lee MS, Moon KC, Kim SH, Cho JY, et al. MDCT findings of renal cell carcinoma associated with Xp11.2 translocation and TFE3 gene fusion and papillary renal cell carcinoma. AJR Am J Roentgenol. 2015 Mar 204(3):542–9. 10.2214/AJR.14.12950

11. Wang HY, Ding HJ, Chen JH, Chao CH, Lu YY, Lin WY, et al. Meta-analysis of the diagnostic performance of [18F]FDG-PET and PET/CT in renal cell carcinoma. Cancer Imaging. 2012 Oct 26;12(3):464–74. 10.1102/1470-7330.2012.0042

12. Liu Y. The place of FDG PET/CT in renal cell carcinoma: Value and limitations. Front Oncol. 2016 Sep 6;6:201. 10.3389/fonc.2016.00201

13. Hou G, Zhao D, Jiang Y, Zhu Z, Huo L, Li F, et al. Clinical utility of FDG PET/CT for primary and recurrent papillary renal cell carcinoma. Cancer Imaging. 2021 Feb 25;21(1):25. 10.1186/s40644-021-00393-8

14. Takahashi M, Kume H, Koyama K, Nakagawa T, Fujimura T, Morikawa T, et al. Preoperative evaluation of renal cell carcinoma by using 18F-FDG PET/CT. Clin Nucl Med. 2015 Dec;40(12): 936–40. 10.1097/RLU.0000000000000875

15. Lidgren A, Bergh A, Grankvist K, Rasmuson T, Ljungberg B. Glucose transporter-1 expression in renal cell carcinoma and its correlation with hypoxia inducible factor-1 alpha. BJU Int. 2008 Feb;101(4):480–4. 10.1111/j.1464-410X.2007.07238.x

16. Aparicio LM, Villaamil VM, Calvo MB, Rubira LV, Rois JM, Ayerbes MV, et al. Glucose transporter expression and the potential role of fructose in renal cell carcinoma: A correlation with pathological parameters. Mol Med Rep. 2010 Jul–Aug;3(4):575–80. 10.3892/mmr_00000300

17. Raj S, Kesari KK, Kumar A, Rathi B, Sharma A, Gupta PK, et al. Molecular mechanism(s) of regulation(s) of c-MET/HGF signaling in head and neck cancer. Mol Cancer. 2022 Jan 26;21(1):31. 10.1186/s12943-022-01503-1

18. Macher-Goeppinger S, Keith M, Endris V, Penzel R, Tagscherer KE, Pahernik S, et al. MET expression and copy number status in clear-cell renal cell carcinoma: Prognostic value and potential predictive marker. Oncotarget. 2017 Jan 3;8(1):1046–57. 10.18632/oncotarget.13540

19. Komai Y, Fujiwara M, Fujii Y, Mukai H, Yonese J, Kawakami S, et al. Adult Xp11 translocation renal cell carcinoma diagnosed by cytogenetics and immunohistochemistry. Clin Cancer Res. 2009 Feb 15;15(4):1170–6. 10.1158/1078-0432.CCR-08-1183